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Abstract 
Review on HOXC8, with data on DNA/RNA, on 
the protein encoded and functions in which this 
gene is implicated. 
Identity 
Other names: HOX3, HOX3A 
HGNC (Hugo): HOXC8 
Location: 12q13.13 
Local order: Orientation: plus strand. 
Note  
This gene is one of several homeobox HOXC genes 
located in a cluster on chromosome 12.  
The product of this gene may play a role in the  
 
regulation of cartilage differentiation (Yueh et al., 
1998).  
It is also involved in chondrodysplasias and other 
cartilage disorders (Cormier et al., 2003; Kamel et 
al., 2009; Yueh et al., 1998). 
DNA/RNA 
Description 
The HOXC8 gene is 3658 nucleotide long and 
consists of two exons.  
There are 112 known SNPs in HOXC8 gene and 
most of them locate on the 5' end of the gene. 
Transcription 
The transcribed matured mRNA is 2290 nucleotide 
in length. 
 
 
Figure 1. A. Schematic representation of human HOXC8 gene. B. Human HOXC8 protein with the indicated position of 
homeodomain (red color) and coiled-coil (blue color). 
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Figure 2. HOXC8 transcription can be regulated by CDX1, AP2d, menin and GTF2IRD1, respectively. The translation of HOXC8 
protein can be blocked by the binding of miR-196s to its 3'UTR. As a transcription factor, HOXC8 is involved in the transcription 
of a variety of genes implicated in embryogenesis and tumorigenesis. 
 
 
Transcription regulators: 1) CDX1, which is a 
member of the caudal-related homeobox 
transcription factor gene family, activates HOXC8 
transcription by binding to its early enhancer (Schyr 
et al., 2012). 2) Activating protein 2 delta (AP2δ) 
transcription factor, which is one of AP2 five 
family members (AP2α, AP2β, AP2γ, AP2δ and 
AP2ε), recruits Ash2I and ALR to the HOXC8 
locus, resulting in H3K4me3-mediated gene 
activation (Tan et al., 2008). 3) Menin, which is a 
tumor suppressor gene associated with a syndrome 
known as multiple endocrine neoplasia type 1, 
binds to HOXC8 locus by associating with a 
histone methyltransferase complex containing two 
trithorax family proteins, MLL2 and Ash2L 
(MacConaill et al., 2006). 4) GTF2IRD1, which is a 
TFII-I family of transcription factors, interacts with 
HOXC8 early enhancer and represses the gene 
transcription (Thompson et al., 2007). 
Protein 
Description 
HOXC8 protein contains 242 amino acids and is 
27755 Da. HOXC8 contains a ~60 amino acid 
homeodomain with helix-turn-helix (HTH) motif 
which functions as a DNA binding domain. 
HOXC8 binds to DNA as monomers or homo- 
and/or heterodimers in a sequence-specific manner. 
Expression 
In mouse embryogenesis: HOXC8 is expressed in 
the neural tube and somatic mesoderm as well as in 
the prospective thorax. During embryogenesis, 
Hoxc8 is initially expressed with the identical 
boundaries in the mesoderm and neurectoderm. 
Subsequently, Hoxc8 expression creeps forward 
and the boundaries in mesoderm and neural tube 
diverge. The gene is also expressed in both the 
neural tube and the somites in the prospective 
thorax (Pollock et al., 1992; Shashikant and Ruddle, 
1996). 
Cancers: Elevated HOXC8 expression is detected in 
breast cancer (Li et al., 2014; Li et al., 2010), 
cervical cancer (Alami et al., 1999), prostate cancer 
(Waltregny et al., 2002), esophageal cancer (Du et 
al., 2014), pancreatic cancer (Adwan et al., 2011). 
Organs: HOXC8 is expressed in hematopoietic 
organs, brain, breast, placenta, liver, bone marrow, 
kidney, intestine and nervous systems, etc. 
Cell types: HOXC8 is expressed on a variety of cell 
types, including fibroblasts, neurons, hair, adipose, 
skeletal and smooth muscle cells, lymph T cells, 
endothelial and epithelial cells, mesenchymal and 
stem cells, etc. 
Translation regulation: Members of microRNA 196 
family (miR-196a1, miR-196a2 and miR-196b) can 
bind to the 3'-UTR of HOXC8 mRNA, leading to 
the repression of HOXC8 translation (Li et al., 
2010). 
Localisation 
Nucleus. 
Function 
HOXC8 serves as a transcription factor to regulate 
the expression of genes that are implicated in 
skeletal and neural development in embryogenesis 
and cancer progression. 
Embryogenesis: Like other HOX proteins, 
HOXC8 plays an essential role in embryo anterior-
posterior patterning and is responsible for skeletal 
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and neural development (Juan et al., 2006; Thickett 
and Morgan, 2002). Null mutants of HOXC8 show 
neuromuscular defects in the forelimb and skeletal 
defects in the ribs and vertebrae of the thorax (Le 
Mouellic et al., 1992). Overexpression of a Hoxc8 
transgene has been shown to cause cartilage defects 
by inhibiting the maturation and stimulating the 
proliferation of chondrocytes (Yueh et al., 1998). 
Transcriptional regulation: As a transcription 
factor, microarray data indicate that HOXC8 
regulates the expression of genes that are involved 
in cell proliferation, migration, adhesion, and 
differentiation (Lei et al., 2005). In response to 
bone morphogenetic protein (BMP) stimulation, 
HOXC8 activates the transcription of osteopontin 
(OPN) by interacting with Smad1 (Shi et al., 1999). 
In breast cancer cells, HOXC8 functions as a 
transcription factor to regulate cadherin 11 (Cdh11) 
transcription (Li et al., 2014; Li et al., 2011). ChIP 
assays demonstrate that HOXC8 can bind to the 
promoter of target genes including NCAM (neural 
cell adhesion molecule), PEDF (pigment 
epithelium-derived factor), ZAC1 (the zinc finger 
protein regulator of apoptosis) and PCNA 
(proliferating cell nuclear antigen) (Lei et al., 2006; 
Min et al., 2010). In addition, HOXC8 has also 
been identified as a transcription repressor. For 
instance, HOXC8 can downregulate the expression 
of Mgl1 and Smad6 by directly binding to the 
promoter regions of these 2 genes (Kang et al., 
2010; Ruthala et al., 2011). 
Stem cells: HOXC8 is expressed in vascular wall-
resident multi-potent stem cells (VW-MPSCs), and 
silencing its expression significantly reduces cell 
sprouting capacity and increases expression of the 
smooth muscle cells marker genes (Klein et al., 
2013). 
Cancers: HOXC8 plays an essential role in cancer 
development, including breast, prostate, cervical 
and pancreatic cancers by facilitating cell migration 
and invasion (Adwan et al., 2011; Alami et al., 
1999; Axlund et al., 2010; Du et al., 2014; Li et al., 
2010). 
Implicated in 
Breast cancer 
Note 
Elevated expression of HOXC8 is found in invasive 
breast cell lines when compared with noninvasive 
breast cell lines. Immunohistochemistry staining 
shows that the level of HOXC8 is higher in breast 
cancer tissues than normal breast tissues (Li et al., 
2010). Ectopic HOXC8 expression induces Cdh11 
expression and promotes breast tumorigenesis (Li et 
al., 2012). Importantly, forced Cdh11 expression 
reverses the inhibitory effect in breast 
tumorigenesis elicited by HOXC8 knockdown (Li  
et al., 2014). Moreover, the analysis of publically 
available human breast tumor microarray gene 
expression database demonstrates a strong positive 
linear association between HOXC8 and CDH11 
expression (R = 0.801, p < 0.001). Survival analysis 
(Kaplan-Meier method, log-rank test) show that 
both high HOXC8 and CDH11 expression 
correlates with poor recurrence-free survival rate of 
patients (Li et al., 2014). Together, these findings 
suggest that HOXC8 promotes breast tumorigenesis 
by maintaining high level of CDH11 expression in 
breast cancer cells. 
Prostate cancer 
Note 
HOXC8 is upregulated in primary prostate tumors, 
lymph node metastases and malignant prostate cell 
lines. HOXC8 overexpression has also been found 
to be correlated with loss of differentiation in 
prostate cancer cell lines and higher Gleason grade 
in prostate tissues.  
These observations suggest that HOXC8 plays a 
role in the acquisition of invasion and metastasis of 
prostate cancer (Miller et al., 2003; Waltregny et 
al., 2002). 
Pancreatic cancer 
Note 
In human pancreatic cancer cell lines, the level of 
HOXC8 mRNA is inversely related to their growth. 
Down-regulation of HOXC8 expression causes 
increased proliferation, migration and colony 
formation, which indicates that HOXC8 is a 
negative regulator of pancreatic cancer cell growth 
and metastasis.  
In primary and metastatic tumor samples, 
immunohistochemistry staining shows that grading 
of primary carcinomas is negatively associated with 
the extent and intensity of HOXC8 staining (Adwan 
et al., 2011). 
Cervical cancer 
Note 
The expression of HOXC8 is turned in in human 
cervical cancer cells while is off in normal cervical 
keratinocytes. This observation indicates that 
HOXC8 is probably involved in the process of 
cervical keratinocytes transformation (Alami et al., 
1999). 
Esophageal cancer 
Note 
Immunohistochemistry staining of 274 patients' 
tissues with esophageal squamous cell carcinoma 
(ESCC) show that HOXC8 expression has a strong 
correlation with 5-year survival rate and increases 
significantly from TNM (tumor & regional lymph 
node & metastasis) stage I to TNM stage III. This 
study indicates that HOXC8 expression may be 
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used as prognostic markers in patients with ESCC 
(Du et al., 2014). 
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